CU20120067A7 - HETEROCYCLIC SULFAMIDE DERIVATIVES AND ITS USE AS MEK INHIBITORS - Google Patents
HETEROCYCLIC SULFAMIDE DERIVATIVES AND ITS USE AS MEK INHIBITORSInfo
- Publication number
- CU20120067A7 CU20120067A7 CU20120067A CU20120067A CU20120067A7 CU 20120067 A7 CU20120067 A7 CU 20120067A7 CU 20120067 A CU20120067 A CU 20120067A CU 20120067 A CU20120067 A CU 20120067A CU 20120067 A7 CU20120067 A7 CU 20120067A7
- Authority
- CU
- Cuba
- Prior art keywords
- mek inhibitors
- sulfamide derivatives
- heterocyclic
- heterocyclic sulfamide
- compounds
- Prior art date
Links
- 239000002829 mitogen activated protein kinase inhibitor Substances 0.000 title abstract 2
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical class NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000003463 hyperproliferative effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a los comp0uestos de la fórmula (IA) ESPACIO PARA FÓRMULA en donde R^1a, R^1b, X, R^2a, R^2b, WW, R^3, R^4, y R^5 son como se definen en la presente, así como a las sales farmacéuticamente aceptables de los mismos. Se han demostrado que los compuestos actúan como inhibidores de MEK, lo cual puede ser útil en el tratamiento de enfermedades hiperproliferativas, como cáncer e inflamacion.The present invention relates to the compounds of formula (IA) SPACE FOR FORMULA wherein R ^ 1a, R ^ 1b, X, R ^ 2a, R ^ 2b, WW, R ^ 3, R ^ 4, and R ^ 5 are as defined herein, as well as pharmaceutically acceptable salts thereof. The compounds have been shown to act as MEK inhibitors, which may be useful in the treatment of hyperproliferative diseases, such as cancer and inflammation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20120067A CU20120067A7 (en) | 2012-04-25 | 2012-04-25 | HETEROCYCLIC SULFAMIDE DERIVATIVES AND ITS USE AS MEK INHIBITORS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20120067A CU20120067A7 (en) | 2012-04-25 | 2012-04-25 | HETEROCYCLIC SULFAMIDE DERIVATIVES AND ITS USE AS MEK INHIBITORS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU20120067A7 true CU20120067A7 (en) | 2012-06-29 |
Family
ID=46516978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20120067A CU20120067A7 (en) | 2012-04-25 | 2012-04-25 | HETEROCYCLIC SULFAMIDE DERIVATIVES AND ITS USE AS MEK INHIBITORS |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU20120067A7 (en) |
-
2012
- 2012-04-25 CU CU20120067A patent/CU20120067A7/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2018013978A2 (en) | Boronic acid derivatives and therapeutic uses thereof. | |
| UY35898A (en) | ? SYK INHIBITING COMPOUNDS AND COMPOSITIONS THAT UNDERSTAND THEM ?. | |
| UY35834A (en) | PIPERAZINAS DE PIRAZOLO REPLACED AS INHIBITORS OF CASEÍNA QUINASA 1 DELTA AND EPSILON | |
| MX2016014547A (en) | Compounds for treating spinal muscular atrophy. | |
| CO7180199A2 (en) | Imidazotriazincarbonitriles useful as kinase inhibitors | |
| CR20160035A (en) | BROMODOMINIUM INHIBITORS | |
| CR20150472A (en) | USE OF PIRAZOLOPIRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3Kd-RELATED DISORDERS | |
| UY35467A (en) | ORGANIC COMPOUNDS | |
| CR20150250A (en) | NEW DERIVATIVES OF PIRIDINA | |
| UY33883A (en) | NEW HETEROCYCLIC DERIVATIVES | |
| MX2016013689A (en) | 4-AMINO-IMIDAZOQUINOLINE COMPOUNDS. | |
| PE20151023A1 (en) | TRIAZOLOPYRAZINES | |
| GT201400031A (en) | DERIVATIVES OF 2-AMINO-4- (PIRIDIN-2-IL) -5,6-DIHIDRO-4H-1,3-OXAZINE AND ITS USE AS BACE-1 AND / OR BACE-2 INHIBITORS | |
| UY33000A (en) | HETEROCYCLIC SULFONAMIDE DERIVATIVES | |
| MX2019010602A (en) | Cdk inhibitors. | |
| UY38712A (en) | FUSED LACTAMS OF ARYL AND HETEROARYL | |
| CR20210079A (en) | SULFAMOILARYLAMIDES AND THEIR USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B | |
| MX2016004742A (en) | DERIVATIVES OF PIRIDIL KETONE, METHOD OF PREPARATION OF THE SAME, AND THE PHARMACEUTICAL APPLICATION OF THE SAME. | |
| MX2019009100A (en) | Novel triazolo[4,5-d]pyrimidine derivatives. | |
| CU20140048A7 (en) | NEW PURINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND NEURODEGENERATIVE DISORDERS | |
| CR20150447A (en) | NEW DERIVATIVES OF PIRAZOL | |
| CR20150378A (en) | TETRACYCLIC COMPOUNDS REPLACED WITH HETEROCICLE AND METHODS OF USE OF THE SAME FOR THE TREATMENT OF VIVIC DISEASES | |
| CR20150555A (en) | NEW DERIVATIVES OF PIRROLO [2,3-D] PYRIMIDINE | |
| UY36228A (en) | HETEROARILO DERIVATIVES AS INHIBITORS OF ALDOSTERONE SINTASA (CYP11B2) AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| PE20151669A1 (en) | AZETIDINYLOXPHENYLPYRROLIDINE COMPOUNDS |